Naproksen
Data klinikal | |
---|---|
Nama dagang | Aleve, Naprelan, Naprosyn, Anaprox, Apronax |
AHFS/Drugs.com | Monograph |
MedlinePlus | a681029 |
Data lesen |
|
Kategori kehamilan |
|
Kod ATC |
|
Status perundangan | |
Status perundangan |
|
Data farmakokinetik | |
Bioketersediaan | 95% (mulut) |
Pengikatan protein | 99% |
Metabolisme | Hati (kepada 6-desmetilnaproksen) |
Penyingkiran separuh hayat | 12–24 jam |
Perkumuhan | Renal |
Pengecam | |
| |
Nombor CAS |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.040.747 |
Data kimia dan fizikal | |
Formula | C14H14O3 |
Jisim molar | 230.259 g/mol |
Model 3D (JSmol) |
|
| |
| |
(verify) |
Naproksen (INN) yang dijula sebagai garam natrium naproksen natrium ialah ubat antiradang bukan steroid (NSAID) dan biasanya digunakan untuk pelegaan pelbagai nyeri, demam, keradangan, dan kekakuan.
Rujukan
Pautan luar
- Aleve U.S.
- Aleve Canada
- CID 1302 daripada PubChem
- Nombor EINECS 244-838-7
- MedlinePlus Information on naproxen
- FDA Statement on Naproxen, released 20 December 2004
- Alzheimer's Disease Anti-Inflammatory Prevention Trial
- Forbes article (expressing the point of view that the risk of heart attack or stroke was overstated)
- Which NSAID for Heart Disease Patients? – Medscape
- U.S. National Library of Medicine: Drug Information Portal – Naproxen
- Aleve Daily Med
- Naproxen bound to proteins in the PDB
- Use of naproxen in the Treatment of RSD